AOD9604 10mg

Product specifications

• Compound: AOD9604
• Peptide content: 10mg per vial
• Brand: Kelden Peptide Sciences Canada

Cartilage and joint research

AOD9604 has been investigated for its potential effects on cartilage repair in experimental osteoarthritis. In a 2015 study involving 32 rabbits with collagenase-induced knee osteoarthritis, AOD9604 was associated with improved cartilage outcomes compared with saline. The combination of AOD9604 and hyaluronic acid produced better cartilage scores than either compound alone and shortened the observed lameness period.

These results support further research into cartilage regeneration and joint tissue preservation. They are animal-model findings, not proof that AOD9604 repairs human cartilage or treats joint pain or osteoarthritis. This retail batch was not the material tested in the cited study.

Research reference: Kwon and Park, 2015 — AOD9604 with or without hyaluronic acid in a rabbit osteoarthritis model.

Aggregation and careful handling

AOD9604 can be susceptible to aggregation and degradation. Stability depends on pH, temperature, concentration, excipients, impurities and handling conditions. Aggregation can affect sample consistency and biological activity.

Avoid vigorous shaking, vortexing and unnecessary mechanical agitation as a precaution. Use gentle handling and a validated laboratory preparation protocol. A specific degree of mechanical-shock sensitivity has not been established for this product; appearance alone cannot confirm the absence of aggregates. Follow batch-specific documentation for storage and verify sample suitability using appropriate analytical methods.

Technical reference: FDA December 2024 review — AOD9604 formulation, stability and aggregation considerations.

Intended use: Laboratory research only. Not for human or veterinary use.

For larger orders, visit our wholesale page to enquire about quantity pricing and availability. Include the product name and required quantity with your enquiry.

Request Wholesale Pricing